Literature DB >> 27022322

Changes of Thyroid Hormones and Their Binding Proteins during Plasma Exchange for Polyneuropathy in a Patient with Substituted Hypothyroidism due to Hashimoto's Thyroiditis.

Stefan Jenni1, Marcel Adler2, Simone Lanz1, Behrouz Mansouri Taleghani2, Emanuel R Christ1.   

Abstract

BACKGROUND: Pharmacodynamic studies and data concerning adaptation of thyroid substitution in patients with substituted hypothyroidism during plasma exchange (PE) is not available. CASE REPORT: We measured TSH, fT3 and fT4, total T4, thyroxin binding globulin (TBG), and albumin before and after 5 PE procedures in a 37-year-old women who underwent PE for a therapy-resistant polyneuropathy. Thyroxin was increased empirically by 8% resulting in a dose of 1.95 µg/kg per day.
RESULTS: Despite larger reductions of total T4 and TBG over a series of 5 PEs (40-50% from baseline), only small reductions of 8% in fT3 and fT4 concentrations were documented with a concomittant increase in TSH level. Changes of fT4, fT3, and TSH remained within normal range.
CONCLUSIONS: i) Despite a significant decrease in total thyroid hormone pool following PE, fT4, fT3, and TSH concentrations changed only slightly. ii) Based on this observation, a general increase in thyroid replacement therapy before PE cannot be recommended, but considered in case of a high normal TSH level.

Entities:  

Keywords:  Hypothyroidism; Plasma exchange; Substitution; Thyroid hormones

Year:  2015        PMID: 27022322      PMCID: PMC4797463          DOI: 10.1159/000440822

Source DB:  PubMed          Journal:  Transfus Med Hemother        ISSN: 1660-3796            Impact factor:   3.747


  11 in total

1.  The effect of double filtration plasmapheresis on thyroid hormone economy and thyroid function.

Authors:  S Sakata; T Komaki; N Kojima; K Miura
Journal:  Jpn J Med       Date:  1986-08

2.  Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the sixth special issue.

Authors:  Joseph Schwartz; Jeffrey L Winters; Anand Padmanabhan; Rasheed A Balogun; Meghan Delaney; Michael L Linenberger; Zbigniew M Szczepiorkowski; Mark E Williams; Yanyun Wu; Beth H Shaz
Journal:  J Clin Apher       Date:  2013-07       Impact factor: 2.821

Review 3.  The mechanisms of action of plasma exchange.

Authors:  Hollie M Reeves; Jeffrey L Winters
Journal:  Br J Haematol       Date:  2013-10-30       Impact factor: 6.998

4.  Effects of human thyroxine-binding globulin and prealbumin on the reverse flow of thyroid hormones from extravascular space into the bloodstream in rabbits.

Authors:  R Wahl; H Schmidberger; E Fessler; W Heinzel; D Schenzle; J Bohner; E Kallee
Journal:  Endocrinology       Date:  1989-03       Impact factor: 4.736

5.  Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III).

Authors:  Joseph G Hollowell; Norman W Staehling; W Dana Flanders; W Harry Hannon; Elaine W Gunter; Carole A Spencer; Lewis E Braverman
Journal:  J Clin Endocrinol Metab       Date:  2002-02       Impact factor: 5.958

6.  Thyroid storm due to inappropriate administration of a compounded thyroid hormone preparation successfully treated with plasmapheresis.

Authors:  Sujeet Jha; Swati Waghdhare; Rajashekar Reddi; Priyanka Bhattacharya
Journal:  Thyroid       Date:  2012-10-15       Impact factor: 6.568

7.  Massive thyroxine intoxication: evaluation of plasma extraction.

Authors:  J Binimelis; L Bassas; L Marruecos; J Rodriguez; M L Domingo; P Madoz; S Armengol; M A Mangues; A de Leiva
Journal:  Intensive Care Med       Date:  1987       Impact factor: 17.440

8.  Preoperative therapeutic plasma exchange in patients with thyrotoxicosis.

Authors:  Ali Ezer; Kenan Caliskan; Alper Parlakgumus; Sedat Belli; Ilknur Kozanoglu; Sedat Yildirim
Journal:  J Clin Apher       Date:  2009       Impact factor: 2.821

9.  World apheresis registry 2003-2007 data.

Authors:  B Stegmayr; J Ptak; B Wikström; G Berlin; C G Axelsson; A Griskevicius; P Centoni; G Liumbruno; P Molfettini; J Audzijoniene; K Mokvist; B Nilsson Sojka; R Norda; F Knutson; W Ramlow; M Blaha; V Witt; M Evergren; J Tomaz
Journal:  Transfus Apher Sci       Date:  2008-10-31       Impact factor: 1.764

10.  Reduction of adverse citrate reactions during autologous large-volume PBPC apheresis by continuous infusion of calcium-gluconate.

Authors:  Christoph Buchta; Maria Macher; Christian Bieglmayer; Paul Höcker; Markus Dettke
Journal:  Transfusion       Date:  2003-11       Impact factor: 3.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.